Provectus Biopharmaceuticals Inc (PVCT) - Medical Equipment - Deals and Alliances Profile
Region:North America
Product Code:GDME82168D
October 2018
22
About the Report
Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. It operates through its offices in Tennessee and New York, the US. Provectus is headquartered in Knoxville, Tennessee, the US.
Provectus Biopharmaceuticals Inc (PVCT)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope of the Report
Products
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 10
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 11
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 12
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 13
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 14
Provectus Pharma Announces Private Placement Of Shares For Up To USD 30 Million 15
Provectus Pharma Completes Private Placement Of Units For USD 2.1 Million 16
Provectus Biopharmaceuticals Inc-Key Competitors 17
Provectus Biopharmaceuticals Inc-Key Employees 18
Provectus Biopharmaceuticals Inc-Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 20
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.